Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab‐paclitaxel for non‐squamous non‐small cell lung cancer with malignant pleural effusion
Motohiro Tamiya, Akihiro Tamiya, Hidekazu Suzuki, Yoshihiko Taniguchi, Kanako Katayama, Shojiro Minomo, Keiko Nakao, Naoko Takeuchi, Yoshinobu Matsuda, Yujiro Naito, Takayuki Shiroyama, Norio Okamoto, Kyoichi Okishio, Toru Kumagai, Shinji Atagi, Fumio Imamura, Tomonori Hirashima
Topics & Concepts
MedicineBevacizumabCarboplatinInternal medicineNeutropeniaPleural effusionPaclitaxelClinical endpointLung cancerChemotherapyGastroenterologyOncologyPhases of clinical researchnon-small cell lung cancer (NSCLC)SurgeryCisplatinClinical trialA549 cellPleural and Pulmonary DiseasesLung Cancer Diagnosis and TreatmentOccupational and environmental lung diseases